EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
In Depth
News image
On Air
News image
Archive
News image
News image
News image
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageMonday, June 21, 1999 Published at 15:44 GMT 16:44 UK
News image
News image
Health
News image
Lymphoma breakthrough halts tumour growth
News image
Gene therapy could hold the key to stopping tumour growth
News image
Treatments which could prevent cancer cells from multiplying could reduce the need for damaging chemotherapy or radiotherapy for some patients.

Canadian research, focused on Hodgkin's Lymphoma, a cancer of the immune system which affects mainly young men, has identified the particular chemical which allows tumour cells to multiply rapidly.

When the chemical was removed, the cancer cells simply stopped growing.

Most Hodgkin's patients are treated with chemotherapy, radiotherapy or a combination of the two.

Scientists found that Interleukin-13, a growth factor, is released by Reed-Sternberg cells, which are the typical cancer cells found in Hodgkin's patients.

Prompts cells to multiply

It appears to be the chemical signal for the Reed-Sternberg cells to reproduce, making the tumour larger and increasing the risk of the cancer spreading.

An examination of genes taken from 950 tumours found IL-13 present in most.


[ image: Chemotherapy can have dangerous long term effects]
Chemotherapy can have dangerous long term effects
Dr Tak W. Mak, senior scientist at the Ontario Cancer Institute, said: "I'm particularly excited because for the first time we have identified the engine that drives at least some Hodgkin's cancer cells to multiply.

"We are now working to find a way to shut down that engine. These findings have huge clinical potential."

Test tube experiments found that tumour cells deprived of their supply of IL-13 simply stopped growing.

Gene technology may now be the way to deal with or block Interleukin-13 production from cancer cells.

Dr Ursula Kapp, from the University Medical Centre in Freiburg, Germany, said: "Now we know IL-13 plays a major role in the growth of at least some Hodgkin's tumours, we can begin to look at new treatments using IL-13 neutralising antibodies or by blocking IL-13 production altogether within Reed-Sternberg cells."

Side effects are dangerous

An alternative, particularly to chemotherapy for Hodgkin's is desirable, particularly as doctors are uncovering long term effects of the powerful treatments used to kill cancer cells, which can be as dangerous as the initial disease itself.

Although the cure rate for Hodgkin's is around four in five, a significant number of patients are falling prey to other cancers, heart disease or, more usually, infertility.

Hodgkin's is a cancer which is often found in people in their 20s and 30s, and affects, in the first instance, tissue of the lymphatic system in the neck, armpits, chest and groin.



News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
29 Apr 99�|�Health
Drug starves cancer tumours
News image
27 Apr 99�|�Health
Doctors investigate 'bowel cancer gene'
News image
21 Apr 99�|�Health
Gene repair breakthrough
News image
31 Mar 99�|�Health
Gene therapy 'could treat brain cancer'
News image
31 Mar 99�|�Health
Cloned embryos 'could treat leukaemia'
News image
08 Jan 99�|�Health
Cancer gene breakthrough
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
Imperial Cancer Research Fund
News image
Lymphoma Association
News image
Hodgkin's Disease and Lymphoma Association
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image